Matthew L. Fedowitz

Grant S. Shackelford

Geoffrey G. Grivner

Andrew R. Cheslock

Kody M. Sparks

Jack B. Blumenfeld

Jennifer H. Roscetti

Megan Dellinger

Danielle A. Duszczyszyn

Jeremy A. Tigan

William B. Raich

Ryan McDonnell

Constance Pei Hwa Lee

Reinaldo F. Machin

ANDA filing triggers AbbVie lawsuit over generic ORILISSA®, accusing Hetero's drug of infringing patents on compositions with `at least about 97 weight percent` purity.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Judge	Period	PO Win Rate
Jennifer L. Hall	01/09/24 - 01/09/24	28%
Richard G. Andrews	04/26/23 - 01/09/24	36%

Name	Ratings
Morris Nichols Arsht & Tunnell LLPLocal	L5 A
Jack B. Blumenfeld	L5 A
Jeremy A. Tigan	L5 B
Megan Dellinger	L3 A
Finnegan Henderson Farabow Garrett & Dunner LLP	L5 B
Jennifer H. Roscetti	L3 B
William B. Raich	L2 A
Danielle A. Duszczyszyn	L2 C
Constance Pei Hwa Lee	L1 C
Ryan McDonnell	L1 D
Reinaldo F. Machin	-- -- --

Name	Ratings
Hetero Labs Ltd	L4 E
Hetero USA Inc	L4 E

Name	Ratings
Buchanan Ingersoll & Rooney	L4 C
Matthew L. Fedowitz	L2 E
Geoffrey G. Grivner	L2 E
Grant S. Shackelford	L1 D
Andrew R. Cheslock	-- -- --
Kody M. Sparks	-- -- --

1:23-cv-00448

AbbVie Inc v. Hetero Labs Ltd